Rofo 2012; 184(7): 607-617
DOI: 10.1055/s-0031-1299332
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Fortgeschrittene interventionelle Techniken und Therapien bei der Behandlung der peripheren arteriellen Verschlusskrankheit vom Unterschenkeltyp

Advanced Interventional Techniques and Therapies in the Treatment of Peripheral Artery Disease Below the Knee
M. Heuschmid
,
D. Ketelsen
,
K. Brechtel
Further Information

Publication History

25 September 2011

30 January 2021

Publication Date:
17 March 2012 (online)

Zusammenfassung

Die Möglichkeiten interventioneller Therapien zur Behandlung der kritischen Extremitätenischämie im Rahmen einer fortgeschrittenen peripheren arteriellen Verschlusskrankheit (pAVK) haben in den letzten Jahren erheblich zugenommen. Insbesondere bei Below-the-Knee(BTK)-Läsionen werden verschiedene antegrade und retrograde Rekanalisierungstechniken angewandt, um die meist komplexen und langstreckigen Stenosen oder Verschlüsse zu passieren. Der aktuelle technische Fortschritt erlaubt die Verwendung unterschiedlicher Draht-, Katheter- und Stenttypen für den therapeutischen interventionellen Einsatz am Unterschenkel. Diese Übersichtsarbeit beschreibt Indikationen, fortgeschrittene Techniken sowie derzeit verwendete Materialien bei cruralen interventionellen Therapieverfahren und fasst aktuelle, evidenzbasierte Studienergebnisse zusammen.

Abstract

In patients with peripheral artery disease, the options for interventional therapy of critical limb ischemia have increased within the last few years. Different antegrade and retrograde techniques for vascular recanalization are used to pass even complex and long stenoses or occlusions below the knee (BTK). A variety of diverse wires, catheters and stent types allows arterial recanalization of the lower leg and increases the impact of therapeutic efforts. This review article describes indications, advanced techniques as well as materials in BTK interventions and summarizes current evidence-based study results.

 
  • Literatur

  • 1 Criqui MH, Fronek A, Barrett-Connor E et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-515
  • 2 Criqui MH, Denenberg JO, Langer RD et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vascular medicine 1997; 2: 221-226
  • 3 Keeling AN, Khalidi K, Leong S et al. Below knee angioplasty in elderly patients: Predictors of major adverse clinical outcomes. Eur J Radiol 2011; 77: 483-489
  • 4 Allaqaband S, Solis J, Kazemi S et al. Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol 2006; 31: 711-760
  • 5 Lumsden AB, Davies MG, Peden EK. Medical and endovascular management of critical limb ischemia. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2009; 16: II31-II62
  • 6 Graziani L, Piaggesi A. Indications and clinical outcomes for below knee endovascular therapy: review article. Catheter Cardiovasc Interv 2010; 75: 433-443
  • 7 Bakal CW, Cynamon J, Sprayregen S. Infrapopliteal percutaneous transluminal angioplasty: what we know. Radiology 1996; 200: 36-43
  • 8 Norgren L, Hiatt WR, Dormandy JA et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007; 26: 81-157
  • 9 DeRubertis BG, Pierce M, Ryer EJ et al. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. Journal of vascular surgery: official publication, the Society for Vascular Surgery (and) International Society for Cardiovascular Surgery, North American Chapter 2008; 47: 101-108
  • 10 Schwarzwalder U, Zeller T. Below-the-knee revascularization. Advanced techniques. J Cardiovasc Surg 2009; 50: 627-634
  • 11 Huppert P, Tacke J, Lawall H. S3 guidelines for diagnostics and treatment of peripheral arterial occlusive disease. Radiologe 2010; 50: 7-15
  • 12 Ladurner R, Kuper M, Konigsrainer I et al. Predictive value of routine transcutaneous tissue oxygen tension (tcpO2) measurement for the risk of non-healing and amputation in diabetic foot ulcer patients with non-palpable pedal pulses. Med Sci Monit 2010; 16: CR273-CR277
  • 13 Zeller T, Sixt S, Rastan A. New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia. VASA. Zeitschrift für Gefäßkrankheiten. Journal for vascular diseases 2009; 38: 3-12
  • 14 Zeller T, Tepe G. Treatment of acute limb ischemia with focus on endovascular techniques. VASA. Zeitschrift für Gefäßkrankheiten. Journal for vascular diseases 2009; 38: 123-133
  • 15 Arain SA, White CJ. Endovascular therapy for critical limb ischemia. Vascular medicine 2008; 13: 267-279
  • 16 Lyden SP, Smouse HB. TASC II and the endovascular management of infrainguinal disease. J Endovasc Ther 2009; 16: II5-II18
  • 17 Rastogi S, Stavropoulos SW. Infrapopliteal angioplasty. Tech Vasc Interv Radiol 2004; 7: 33-39
  • 18 Schanzer A, Conte MS. Critical limb ischemia. Curr Treat Options Cardiovasc Med 2010; 12: 214-229
  • 19 Adam DJ, Beard JD, Cleveland T et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934
  • 20 Bolia A. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg 2005; 46: 385-394
  • 21 Scheinert D, Laird Jr JR, Schroder M et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2001; 8: 156-166
  • 22 Laird JR, Zeller T, Gray BH et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2006; 13: 1-11
  • 23 Garcia-Garcia HM, Brugaletta S, van Mieghem CA et al. Crosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success. EuroIntervention 2011; 7: 480-486
  • 24 Khalid MR, Khalid FR, Farooqui FA et al. A novel catheter in patients with peripheral chronic total occlusions: a single center experience. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2010; 76: 735-739
  • 25 Gandini R, Volpi T, Pipitone V et al. Intraluminal recanalization of long infrainguinal chronic total occlusions using the Crosser system. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2009; 16: 23-27
  • 26 Bausback Y, Botsios S, Flux J et al. Outback catheter for femoropopliteal occlusions: immediate and long-term results. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2011; 18: 13-21
  • 27 Etezadi V, Benenati JF, Patel PJ et al. The reentry catheter: a second chance for endoluminal reentry at difficult lower extremity subintimal arterial recanalizations. J Vasc Interv Radiol 2010; 21: 730-734
  • 28 Shin SH, Baril D, Chaer R et al. Limitations of the Outback LTD re-entry device in femoropopliteal chronic total occlusions. Journal of vascular surgery: official publication, the Society for Vascular Surgery (and) International Society for Cardiovascular Surgery, North American Chapter 2011; 53: 1260-1264
  • 29 Husmann MJ, Kickuth R, Ludwig K et al. Intravascular ultrasound-guided creation of re-entry sites to improve intermittent claudication in patients with aortic dissection. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2006; 13: 424-428
  • 30 Schwarzwalder U, Zeller T. Below-the-knee revascularization. Advanced techniques. The Journal of cardiovascular surgery 2009; 50: 627-634
  • 31 Casserly IP, Rogers RK. Use of Stingray re-entry system in treatment of complex tibial artery occlusive disease. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2010; 76: 584-588
  • 32 Spinosa DJ, Harthun NL, Bissonette EA et al. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol 2005; 16: 37-44
  • 33 Fusaro M, Dalla Paola L, Biondi-Zoccai GG. Retrograde posterior tibial artery access for below-the-knee percutaneous revascularization by means of sheathless approach and double wire technique. Minerva cardioangiologica 2006; 54: 773-777
  • 34 Fusaro M, Dalla Paola L, Biondi-Zoccai G. Pedal-plantar loop technique for a challenging below-the-knee chronic total occlusion: a novel approach to percutaneous revascularization in critical lower limb ischemia. The Journal of invasive cardiology 2007; 19: E34-E37
  • 35 Manzi M, Fusaro M, Ceccacci T et al. Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries. The Journal of cardiovascular surgery 2009; 50: 331-337
  • 36 Fusaro M, Agostoni P, Biondi-Zoccai G. “Trans-collateral” angioplasty for a challenging chronic total occlusion of the tibial vessels: a novel approach to percutaneous revascularization in critical lower limb ischemia. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2008; 71: 268-272
  • 37 Dorros G, Jaff MR, Dorros AM et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001; 104: 2057-2062
  • 38 Parsons RE, Suggs WD, Lee JJ et al. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting?. Journal of vascular surgery: official publication, the Society for Vascular Surgery (and) International Society for Cardiovascular Surgery, North American Chapter 1998; 28: 1066-1071
  • 39 Treiman GS, Treiman RL, Ichikawa L et al. Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?. Journal of vascular surgery: official publication, the Society for Vascular Surgery (and) International Society for Cardiovascular Surgery, North American Chapter 1995; 22: 457-463 ; discussion 464-455
  • 40 Bradbury AW, Adam DJ, Bell J et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010; 51: 18S-31S
  • 41 Romiti M, Albers M, Brochado-Neto FC et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. Journal of vascular surgery: official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2008; 47: 975-981
  • 42 Bosiers M, Hart JP, Deloose K et al. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006; 14: 63-69
  • 43 Schmidt A, Ulrich M, Winkler B et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2010; 76: 1047-1054
  • 44 Brechtel K. Endovascular therapy options in femoro-popliteal PAD. Fortschr Röntgenstr 2010; 182: 755-763
  • 45 Bosiers M, Deloose K, Cagiannos C et al. Use of the AngioSculpt scoring balloon for infrapopliteal lesions in patients with critical limb ischemia: 1-year outcome. Vascular 2009; 17: 29-35
  • 46 Rand T, Basile A, Cejna M et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovascular and interventional radiology 2006; 29: 29-38
  • 47 Bosiers M, Deloose K, Verbist J et al. Nitinol stenting for treatment of “below-the-knee” critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. The Journal of cardiovascular surgery 2007; 48: 455-461
  • 48 Bosiers M, Peeters P, D’Archambeau O et al. AMS INSIGHT – absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32: 424-435
  • 49 Axel DI, Kunert W, Goggelmann C et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96: 636-645
  • 50 Speck U, Scheller B, Abramjuk C et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006; 240: 411-418
  • 51 Albrecht T, Speck U, Baier C et al. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 2007; 42: 579-585
  • 52 Bosiers M, Deloose K, Verbist J et al. Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. The Journal of cardiovascular surgery 2006; 47: 171-176
  • 53 Scheinert D, Ulrich M, Scheinert S et al. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2006; 2: 169-174
  • 54 Siablis D, Kraniotis P, Karnabatidis D et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2005; 12: 685-695
  • 55 Zeller T, Schmitmeier S, Tepe G et al. Drug-coated balloons in the lower limb. The Journal of cardiovascular surgery 2011; 52: 235-243
  • 56 Tepe G, Schmehl J, Heller S et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers--The BELOW Study. J Cardiovasc Surg 2010; 51: 203-212
  • 57 Cremers B, Speck U, Kaufels N et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 2009; 101: 201-206
  • 58 Tepe G, Zeller T, Albrecht T et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008; 358: 689-699
  • 59 Freyhardt P, Zeller T, Kroncke TJ et al. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries. Fortschr Röntgenstr 2011; 183: 448-455
  • 60 Werk M, Langner S, Reinkensmeier B et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-1365
  • 61 Bosiers M, Deloose K, Callaert J et al. Drug-eluting stents below the knee. The Journal of cardiovascular surgery 2011; 52: 231-234
  • 62 Mauri L, Orav EJ, Candia SC et al. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 2005; 112: 2833-2839
  • 63 Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2006; 68: 793-798
  • 64 Rastan A, Tepe G, Krankenberg H et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J 2011; 32: 2274-2281
  • 65 Duda SH, Bosiers M, Lammer J et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16: 331-338
  • 66 Duda SH, Bosiers M, Lammer J et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists 2006; 13: 701-710
  • 67 Siablis D, Karnabatidis D, Katsanos K et al. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol 2007; 18: 1351-1361
  • 68 Zeller T, Sixt S, Schwarzwalder U et al. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther 2007; 14: 232-240
  • 69 Hwang C, Levin A, Jonas M et al. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation 2005; 111: 1619-1626